Bliss GVS Pharma Limited (BOM:506197)
India
· Delayed Price · Currency is INR 204.50
-9.50 (-4.44%)
At close: Mar 9, 2026
Bliss GVS Pharma Market Cap
Bliss GVS Pharma has a market cap or net worth of 21.63 billion as of March 9, 2026. Its market cap has increased by 55.25% in one year.
Market Cap
21.63B
Enterprise Value
20.51B
Revenue
8.68B
Ranking
n/a
PE Ratio
20.07
Stock Price
204.50
Market Cap Chart
Since January 11, 2002, Bliss GVS Pharma's market cap has increased from 10.05M to 21.63B, an increase of 215,120.61%. That is a compound annual growth rate of 37.37%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Unichem Laboratories | 22.81B |
| Hikal | 22.33B |
| Novartis India | 22.97B |
| Morepen Laboratories | 21.81B |
| Gufic Biosciences | 28.00B |
| Shukra Pharmaceuticals | 18.14B |
| Amrutanjan Health Care | 16.15B |
| Kwality Pharmaceuticals | 15.05B |